KWEB (Chinese Internet ETF) Pushes Up Against Multi-Year Resistance
by Mike Paulenoff
August 24, 2025 • 4:00 PM EDT
On February 18, 2025, this is what I posted on MPTrader about KWEB (Chinese Internet ETF) that alerted traders to a potentially explosive setup that should keep KWEB on our radar screens going forward :
My attached Daily Chart shows that KWEB is attempting to emerge from a huge, three-year rounded base-accumulation setup that projects much higher prices as the price structure climbs the "recovery wall of worry" in the aftermath of the relentless bear phase from the February 2021 ATH at 104.94 to the October 2022 low at 17.22... Last is 35.60...
This past Friday (8/22/25), KWEB recorded a post-market final trade of 38.58, above its 11-month down trendline, pushing up against a multi-year resistance zone between 38.80 and 39.40 that, if (when?) hurdled and sustained, will trigger much higher intermediate-term price potential (See my attached Daily Chart).
Although the underlying reasons for the pent-up price strength are debatable, such as reduced perceived trade tensions between the U.S. and China, Chinese Government policy support, Chinese breakthroughs in AI technology, and relatively attractive valuations compared to U.S. big tech companies, there is less debate that, technically, the 3+ year base-accumulation period is telling us something very positive is brewing in the Chinese tech sector.
In any case, next week in particular, with NVDA reporting Earnings on Wednesday evening, should be extremely telling for KWEB as well.
Join us ASAP at MPTrader for our ongoing analysis and discussion about KWEB, as well as many other ETFs, individual stocks, macro indices, commodities, precious metals, and cryptocurrencies...
Mike Paulenoff is the author of MPTrader.com, a real-time diary of his technical analysis & trade alerts on
ETFs for precious metals, energy, currencies, and an array of equity indices and sectors, including international
markets, plus key ETF component stocks in sectors like technology, mining, and banking.
Sign up for a Free 7-day Trial!
On July 29, 2025, this is what we discussed about TEVA (Teva Pharma), accompanied by my then-current 4-Hour Chart, just ahead of Earnings:My attached 4-Hour Chart setup argues that TEVA is poised for upside continuation of its April-May advance (12.47 to 18.67) EITHER right from current levels in reaction to a positive Earnings Report tomorrow morning, OR into a BTD bout of weakness into the 14.85-15.55 target support window.
On the morning of August 6th, I posted the chart below after seeing Fundstrat's Tom Lee discuss his CEO position in BMNR (BitMine Immersion Technologies), and the fact that BMNR was accumulating a large cache of Ethereum (ETH) that will serve as an ETH Treasury holding similar to the Bitcoin model used by Microstrategy's Michael Saylor. At the time, BNMR had climbed from 31.85 to 33.70, which piqued my attention technically:"BNMR ... once again is putting upward pressure on the 34.
Nearly two months ago, I posted my technical setup on TMO (Thermo Fisher Scientific, Inc.) to alert MPTrader members to a potentially significant upside reversal pattern. Here is my commentary from June 3, 2025:My attached Big Picture Daily Chart shows the major bear phase from the 9/10/24 ATH at 627.88 to last week's (5/23/25) low at 390.66 (-38%). Most interestingly, all of the price action from the 4/09/25 low at 409.
Every person on the planet is now aware that early on Saturday night, June 21st, 2025, the U.S. military attacked and severely damaged (destroyed?) Iran's nuclear sites and presumably their ability to produce nuclear materials needed to create a WMD.
Last Wednesday afternoon (6/11/25), with META circling 700 after establishing a 4-month new post-April 2025 recovery rally high at 708.87, this is what we discussed about the current technical setup: Just a heads up that my pattern work is warning me that the 52% upmove from the 4/07 low at 467.31 to today's (6/11) high at 708.87 has the right look of a completed, overextended, overbought, unconfirmed rally peak that leaves the price structure vulnerable to a correction of some magnitude.